Next On SCOTUS: A Significant Case For Drug Manufacturers

Law360, New York (January 17, 2013, 2:10 PM EST) -- Sometime in the next few months, the U.S. Supreme Court will hear arguments on the appeal of Mutual Pharmaceutical Co. v. Bartlett, 678 F.3d 30 (1st Cir. 2012), a First Circuit decision that dramatically narrowed the scope of the Supreme Court's prior decision, Pliva v. Mensing, 113 S.Ct. 2567 (2011). The Bartlett appeal may have significant repercussions for generic drug manufacturers, who — for more than a year — have successfully relied on Mensing to insulate themselves from liability against product liability claims....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!